9 Results for "

levamisole

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "levamisole" in MCE Product Catalog:

17
17 Cited Publications
Cat. No.: HY-13666
CAS No.: 16595-80-5
Purity:  99.86%
Synonyms: (-)-Tetramisole hydrochloride
Target:  

Parasite HSV

Research Areas:  

Infection Neurological Disease Cancer

Levamisole ((-)-Tetramisole) hydrochloride is an anthelmintic and immunomodulator belonging to a class of synthetic imidazothiazole derivatives. Levamisole hydrochloride has antiviral effects against HSV.
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-A0106
CAS No.: 14769-73-4
Synonyms: (-)-Tetramisole
Target:  

nAChR Parasite

Levamisole ((-)-Levamisole), an anthelmintic agent with immunomodulatory properties. Levamisole acts as a positive allosteric modulator (PAM) for the α3β2 (EC50=300 μM) and α3β4 (EC50=100 μM) subtype of nAChRs. Orally active .
loading...
    loading...
Cat. No.: HY-13666S
CAS No.: 1246819-64-6
Synonyms: (-)-Tetramisole-d5 hydrochloride
Levamisole-d5 (hydrochloride) is the deuterium labeled Levamisole hydrochloride. Levamisole ((-)-Tetramisole) hydrochloride is an anthelmintic and immunomodulator belonging to a class of synthetic imidazothiazole derivatives. Levamisole hydrochloride has antiviral effects against HSV .
loading...
    loading...
Cat. No.: HY-13666R
CAS No.: 16595-80-5
Synonyms: (-)-Tetramisole hydrochloride (Standard)
Levamisole (hydrochloride) (Standard) is the analytical standard of Levamisole (hydrochloride). This product is intended for research and analytical applications. Levamisole ((-)-Tetramisole) hydrochloride is an anthelmintic and immunomodulator belonging to a class of synthetic imidazothiazole derivatives. Levamisole hydrochloride has antiviral effects against HSV.
loading...
    loading...
Cat. No.: HY-A0106R
CAS No.: 14769-73-4
Synonyms: (-)-Tetramisole (Standard)
Levamisole (Standard) is the analytical standard of Levamisole. This product is intended for research and analytical applications. Levamisole ((-)-Levamisole), an anthelmintic agent with immunomodulatory properties. Levamisole acts as a positive allosteric modulator (PAM) for the α3β2 (EC50=300 μM) and α3β4 (EC50=100 μM) subtype of nAChRs. Orally active .
loading...
    loading...
Cat. No.: HY-106050
CAS No.: 58433-11-7
Synonyms: Wy 18251
Target:  

COX

Research Areas:  

Inflammation/Immunology Cancer

Tilomisole (Wy 18251) is a benzimidazothiazole experimental agent with anti-inflammatory activity. Tilomisole causes less agranulocytosis than levamisole, but retains immunomodulating capabilities. Tilomisole is orally active. Tilomisole has the potential for the research of cancer and inflammation .
loading...
    loading...
Cat. No.: HY-121856
CAS No.: 36740-73-5
Target:  

Others

Research Areas:  

Inflammation/Immunology

Flumizole, a derivative of substituted 5,6-diaryl-2,3-dihydroimidazo[2,1-b]thiazoles, was synthesized and evaluated for its immunoregulatory and anti-inflammatory properties in animal models such as rat adjuvant-induced arthritis and mouse oxazolone-induced contact sensitivity assays. This compound class combines structural elements from flumizole and levamisole, aiming to enhance therapeutic efficacy. Symmetrically substituted 5,6-diaryl compounds with specific alkyl heteroatom or halogen substitutions showed optimal potency in the arthritis model. However, variations in activity were less consistent in the contact sensitivity assay. Flumizole and related compounds demonstrate potential as dual-action agents, targeting inflammation and immune modulation, offering promise for therapeutic development in immune-related disorders .
loading...
    loading...
Cat. No.: HY-183947
CAS No.: 56943-06-7
Research Areas:  

Cancer

4-Bromolevamisole, an analogues of Levamisole (HY-A0106), is a phosphatase inhibitor. 4-Bromolevamisole potentiates the antineoplastic activity of 5-Fluorouracil (HY-90006), its analogues, or prodrugs thereof.4-Bromolevamisole can be used for cancer research .
loading...
    loading...
Cat. No.: HY-W677714
CAS No.: 163105-64-4
Research Areas:  

Infection

SDH-IN-43 (Compound i-19) is a succinate dehydrogenase (SDH) inhibitor. SDH-IN-43 shows potent inhibitory activity against caenorhabditis elegans wirh an IC50 of 6.67 μM. SDH-IN-43 can significantly reduce caenorhabditis elegans reproductive ability and movement ability, and is also effective against drug-resistant strains of Levamisole (HY-A0106), Benzimidazole (HY-Y1825), and Ivermectin (HY-15310). SDH-IN-43 can be used for the research of parasite infection .
loading...
    loading...